These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19748500)

  • 1. Impact of quality control accepted inter-laboratory variations on calculated Fibrotest/Actitest scores for the non-invasive biochemical assessment of liver fibrosis.
    Gressner OA; Beer N; Jodlowski A; Gressner AM
    Clin Chim Acta; 2009 Nov; 409(1-2):90-5. PubMed ID: 19748500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrotest-Actitest: the biochemical marker of liver fibrosis--the Israeli experience.
    Morali G; Maor Y; Klar R; Braun M; Ben Ari Z; Bujanover Y; Zuckerman E; Boger S; Halfon P
    Isr Med Assoc J; 2007 Aug; 9(8):588-91. PubMed ID: 17877064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results transferability on RXL, ARX, X-Pand, BN2 (Dade Behring) and modular DP (Roche Diagnostics) analysers: application to component assays of fibrotest and Actitest].
    Imbert-Bismut F; Messous D; Raoult A; Poynard T; Bertrand JJ; Marie PA; Louis V; Audy C; Thouy JM; Hainque B; Piton A
    Ann Biol Clin (Paris); 2005; 63(3):305-13. PubMed ID: 15951262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors.
    Imbert-Bismut F; Messous D; Thibault V; Myers RB; Piton A; Thabut D; Devers L; Hainque B; Mercadier A; Poynard T
    Clin Chem Lab Med; 2004 Mar; 42(3):323-33. PubMed ID: 15080567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alpha 2 macroglobulin immunoturbidimetric assays (DakoCytomation reagents) on Roche Diagnostic analysers (Modular P, Cobas Integra). Application to FibroTest-Actic-Test].
    Piton A; Messous D; Imbert-Bismut F; Bergès J; Munteanu M; Poynard T; Hainque B
    Ann Biol Clin (Paris); 2005; 63(4):385-95. PubMed ID: 16061437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive biomarkers FibroTest and ActiTest versus liver biopsy in chronic hepatitis C patients: the Middle East experience.
    Yakoob R; Bozom IA; Thandassery RB; Rahman MO; Derbala MF; Mohannadi MJ; John AK; Sharma M; Wani H; Kaabi SA
    Ann Gastroenterol; 2015; 28(2):265-270. PubMed ID: 25830472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of FibroTest-ActiTest with histopathology in demonstrating fibrosis and necroinflammatory activity in chronic hepatitis B and C.
    Uyar C; Akcam FZ; Ciris M; Kaya O; Kockar C; Isler M
    Indian J Pathol Microbiol; 2010; 53(3):470-5. PubMed ID: 20699505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the non-invasive serum marker FibroTest-ActiTest in the prediction of histological stage of fibrosis and activity in children with naïve chronic hepatitis B infection.
    Sökücü S; Gökçe S; Güllüoğlu M; Aydoğan A; Celtik C; Durmaz O
    Scand J Infect Dis; 2010 Sep; 42(9):699-703. PubMed ID: 20429710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility of blood tests of liver fibrosis in clinical practice.
    Calès P; Veillon P; Konaté A; Mathieu E; Ternisien C; Chevailler A; Godon A; Gallois Y; Joubaud F; Hubert-Fouchard I; Oberti F; Réaud S; Hunault G; Mauriat F; Lunel-Fabiani F
    Clin Biochem; 2008 Jan; 41(1-2):10-8. PubMed ID: 17988658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel panel of blood markers to assess the degree of liver fibrosis.
    Calès P; Oberti F; Michalak S; Hubert-Fouchard I; Rousselet MC; Konaté A; Gallois Y; Ternisien C; Chevailler A; Lunel F
    Hepatology; 2005 Dec; 42(6):1373-81. PubMed ID: 16317693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal correlation between different instruments for Fibrotest-Actitest protein measurement in patients with chronic hepatitis C.
    Rosenthal-Allieri MA; Tran A; Halfon P; Imbert-Bismut F; Munteanu M; Messous D; Peritore ML; Poynard T; Bernard A
    Gastroenterol Clin Biol; 2007 Oct; 31(10):815-21. PubMed ID: 18166859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests.
    Gressner OA; Weiskirchen R; Gressner AM
    Clin Chim Acta; 2007 Jun; 381(2):107-13. PubMed ID: 17399697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection.
    Poynard T; Zoulim F; Ratziu V; Degos F; Imbert-Bismut F; Deny P; Landais P; El Hasnaoui A; Slama A; Blin P; Thibault V; Parvaz P; Munteanu M; Trepo C
    Am J Gastroenterol; 2005 Sep; 100(9):1970-80. PubMed ID: 16128941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FibroTest-ActiTest as a non-invasive marker of liver fibrosis.
    Halfon P; Munteanu M; Poynard T
    Gastroenterol Clin Biol; 2008 Sep; 32(6 Suppl 1):22-39. PubMed ID: 18973844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients.
    Bottero J; Lacombe K; Guéchot J; Serfaty L; Miailhes P; Bonnard P; Wendum D; Molina JM; Lascoux-Combe C; Girard PM
    J Hepatol; 2009 Jun; 50(6):1074-83. PubMed ID: 19398234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference.
    Munteanu M; Tiniakos D; Anstee Q; Charlotte F; Marchesini G; Bugianesi E; Trauner M; Romero Gomez M; Oliveira C; Day C; Dufour JF; Bellentani S; Ngo Y; Traussnig S; Perazzo H; Deckmyn O; Bedossa P; Ratziu V; Poynard T;
    Aliment Pharmacol Ther; 2016 Oct; 44(8):877-89. PubMed ID: 27549244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FibroTest-FibroSURE: towards a universal biomarker of liver fibrosis?
    Poynard T; Imbert-Bismut F; Munteanu M; Ratziu V
    Expert Rev Mol Diagn; 2005 Jan; 5(1):15-21. PubMed ID: 15723588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.
    Leroy V; Hilleret MN; Sturm N; Trocme C; Renversez JC; Faure P; Morel F; Zarski JP
    J Hepatol; 2007 May; 46(5):775-82. PubMed ID: 17321634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest).
    Munteanu M; Messous D; Thabut D; Imbert-Bismut F; Jouys M; Massard J; Piton A; Bonyhay L; Ratziu V; Hainque B; Poynard T
    Comp Hepatol; 2004 Jun; 3(1):3. PubMed ID: 15214966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.